Probiotic powder ameliorates colorectal cancer by regulating Bifidobacterium animalis , Clostridium cocleatum , and immune cell composition
PLOS ONE · 15 authors, 8 centres
AI SUMMARY
FIDELITY 100%
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This study used a mouse model of colorectal cancer to test a new probiotic powder.
Full summary
460 CHARS
This preclinical study evaluated a new probiotic powder in a mouse model of colorectal cancer (CRC). The researchers assessed the powder's effect on mouse survival, tumor size, intestinal barrier integrity, gut microbiota composition via 16S rDNA sequencing, immune cell populations via flow cytometry, and apoptotic protein expression via western blot. Limitations include the need for further study on specific mechanisms and potential combination therapies.